PharmaKure and UiTM Team up To Research in Alzheimer's Disease

One of the most comprehensive universities in Malaysia, Universiti Teknologi MARA (UiTM), has signed a research cooperation agreement with PharmaKure, a clinical stage startup creating precision medicine for Alzheimer's disease and other...

Imugene and NeoImmuneTech Sign Pact To Improve Cancer Treatments

A strategic collaboration was announced by clinical-stage T-cell-focused biopharmaceutical company NeoImmuneTech, Inc. (NIT) and clinical-stage immuno-oncology company Imugene Ltd (Imugene) to assess the potential of Imugene's allogeneic CAR T...

CareStack Acquires Waybeo For Patient Communications Growth with AI

CareStack has acquired Waybeo, a co-founded Indian firm that provides advanced intelligence services in ad-generated phone calls. By combining Waybeo's cutting-edge technology with CareStack's market dominance in dental care, the purchase will...

AstraZeneca and Roche Sign Mou To Improve Breast Cancer Diagnostics

AstraZeneca Pharma India Ltd and Roche Diagnostics India signed a memorandum of understanding (MoU) to improve diagnostics for breast cancer patients, with a particular emphasis on simplifying HER2 diagnostics with contemporary breakthroughs in...

SkylineDx and VIB Joins for Research Programme on Immune Prediction

SkylineDx has announced that Pointillism 2.0, a collaborative precision medicine project, has been selected for financing as part of the renowned VIB Grand Challenges Programme. This program intends to promote the advancement of socially relevant...

Medtronic and Cosmo Pharma Widen Ties To Deliver Continued Innovation

Medtronic plc, a global leader in healthcare technology announced the signing of a final agreement to expand its collaboration with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven collaboration will...

Zydus and Daewoong Pharma Sign Deal To Develop Leuprolide Acetate

Zydus Lifesciences Ltd signed a licensing agreement with Daewoong Pharmaceutical Co Ltd of South Korea on Monday to co-develop and commercialize a generic version of Leuprolide Acetate for depot suspension, which is used to treat advanced...

PNB VESPER and NIH-NIDA Ink Pact To Develop Drugs for Disorders

PNB VESPER, a Kochi-based research-based biopharmaceutical company, has signed agreements with the National Institute on Drug Abuse (NIDA), the lead federal agency supporting scientific research on drug abuse and addiction disorders, to develop...

Astellas Pharma Bags US FDA Nod For Cresemba To Treat Invasive Aspergillosis

As per Astellas Pharma US, Inc. Cresemba (isavuconazonium sulfate), an azole antifungal medication, has been approved by the US Food and medication Administration (FDA) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis...

Sanofi and Minapharm Ink Pact To Manufacture Clexane

Sanofi and Minapharm have announced the signing of an exclusive Manufacturing and Supply Agreement for the localization of the entire Clexane product line. The agreement between Sanofi, a global pharmaceutical company and Egypt's Minapharm...

© 2024 India Pharma Outlook. All Rights Reserved.